Netherlands· NL-b049aa91895a
Ramipril Accord 5 mg, capsule hard
A ramipril product containing ramipril, registered in Netherlands by Accord Healthcare B.V.. The same ATC class is registered in 18 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ramipril is registered in 18 of 19 countries.
Countries holding a registration under ATC C09AA05 (ramipril), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 11 of them publish a price we can compare per daily dose
Ramipril · ATC C09AA05
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ramipril costs, country by country.
Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.026 in United States to $0.40 in Switzerland — a ×15 gap.
- 5 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Ramipril · price per daily dose (2.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.40
- ES Spain$0.098
- FR France$0.096
- IT Italy$0.073
- US United States$0.026 (acquisition cost)
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- RAMIPRIL
- Manufacturer
- Accord Healthcare B.V.
- Country
- Netherlands (NL)
- ATC code
- C09AA05
- ATC class
- Ramipril
- Defined daily dose
- 2.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id110568
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
458 interactions on record for ramipril.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ramipril · interactions on record
458 records
- 11 severe
- 166 moderate
- 17 minor
- 184 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
80 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ramipril in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomLopace 5mg capsulesDiscovery Pharmaceuticals
- United StatesRamiprilHikma Pharmaceuticals USA Inc.
- CanadaAG-RAMIPRILANGITA PHARMA INC.
- BelgiumRamipril/Amlodipine AB 5 mg - 10 mgAurobindo
- PolandPolprilZakłady Farmaceutyczne POLPHARMA S.A.
- CzechiaAMPRILANKrka, d.d., Novo mesto, Novo mesto
- FinlandCardaceSanofi Oy
- ItalyECLIPSES.F. GROUP S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Lannapril, Ramipril 1a Pharma
- Belgium · Ramipril Ab, Ramipril Eg
- Bulgaria · Cardifriend, Cardifriend 10 Mg
- Cyprus · Acapril, Ramimed
- Czechia · Amprilan, Piramil
- Germany · Delix, Delix P
- Denmark · Alarimed, Polpril
- Estonia · Ampril, Cardace
- Spain · Acovil, Ramipril Alter Genéricos
- Finland · Cardace, Ramipril Hexal
- France · Ramipril Almus, Ramipril Arrow Generiques
- United Kingdom (Northern Ireland) · Ramipril, Ramipril Accord Healthcare
- Greece · Piramil, Ramisyn
- Croatia · Ampril, Blocar
- Hungary · Amprilan, Hartil
- Ireland · Ramic, Ramilo
- Iceland · Ramíl
- Italy · Herzatec, Krupil
- Lithuania · Ampril, Cardace
- Luxembourg · Ramipril Eg, Tritace
- Latvia · Cardace, Ramicor
- Malta · Ramipril Aurobindo, Ramipril Tad
- Norway · Ramipril Actavis, Ramipril Hexal
- Poland · Ampril, Aporami
- Portugal · Ramipril Alter, Ramipril Aurovitas
- Romania · Ampril, Ramipril Ac
- Sweden · Ramiliv, Ramipril Aurobindo
- Slovenia · Ampril, Piramil
- Slovakia · Ampril, Piramil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/186735be-2d7a-4975-8ae4-13504ad2d6b0 GET /v1/drugs/186735be-2d7a-4975-8ae4-13504ad2d6b0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h110568_smpc.pdf",
"strength": null,
"atc_label": "Ramipril",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg110568",
"excipients": [
"ERYTHROSINE (E 127)",
"GELATINE (E 441)",
"IJZEROXIDE ZWART (E 172)",
"KALIUMHYDROXIDE (E 525)",
"MAÏSZETMEEL, GEPREGELATINEERD",
"PATENTBLAUW V (E 131)",
"PROPYLEENGLYCOL (E 1520)",
"SCHELLAK (E 904)",
"TITAANDIOXIDE (E 171)",
"ZWARTE INKT"
],
"substances": [
"RAMIPRIL"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h110568.pdf",
"authorised_at": "2013/03/18",
"procedure_number": "NL/H/2445/003",
"dispensing_status": "Uitsluitend recept",
"registration_number": "110568",
"additional_monitoring": "N"
}See everything about ramipril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.